LONDON (Reuters) - The world urgently needs a quality-assured supply of injectable artesunate, a drug that tests have shown is significantly better than quinine in treating severe malaria, medical experts said on Friday.
Intravenous quinine is currently the only drug recommended throughout Africa, South America and most of Asia for severe cases of the mosquito-borne disease, where the death rate is more than one in five.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
